Home Categories API Abacavirsulfate
A7081958

Abacavirsulfate , 10mMinWater , 188062-50-2

Synonym(s):
(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol sulfate;{(1S, 4R)-4-[2-Amino-6- (cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol};Abacavir Hemisulfate;Abacavir sulfate;ABC

CAS NO.:188062-50-2

Empirical Formula: C28H38N12O6S

Molecular Weight: 670.74

MDL number: MFCD04112763

EINECS: 620-488-4

Pack Size Price Stock Quantity
1ml RMB559.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 222-225°C
storage temp.  2-8°C
solubility  H2O: ≥17mg/mL
form  powder
color  white to tan
optical activity [α]/D -30 to -40°, c = 0.5 in methanol
Water Solubility  1.68ug/L(32 ºC)
BCS Class 3
CAS DataBase Reference 188062-50-2(CAS DataBase Reference)

Description and Uses

Abacavir sulfate was first launched as Ziagen in the US for the treatment of human immunodeficiency virus (HIV) infection, in combination with other antiretroviral drugs. Abacavir is a carbocyclic nucleoside reverse transcriptase inhibitor (nRTI); it is one of the most potent anti-HIV agents to date. In vitro, Abacavir is a potent and selective inhibitor of HIV-1 and HIV-2 replication. Resistance to Abacavir develops more slowly than for other anti-HIV agents. Abacavir is highly synergistic with protease inhibitors such as Amprenavir. In clinical trials for HIV infections in adults, it produced durable suppression in viral load. Combinations with different protease inhibitors such as Nelfinavir, Saquinavir or Indinavir markedly reduced plasma viral load to undetectable levels for at least 48 weeks, and significantly raised CD4+ cell counts in adults with HIV infection, especially nRTI-naive patients. Abacavir has a good oral availability and its penetration into CSF is much more significant than for other anti-HIV drugs. The two major metabolites identified in humans were the 5'-carboxylate and the 5'-glucuronide, mainly excreted via the renal route.

Abacavir sulfate is a nucleoside reverse transcriptase inhibitor (NRTI) used for the treatment of HIV-1 infection and anti-AIDS drug. It has been used in the cytotoxicity to test its tumour promoting activity U937 cells.

Safety

Symbol(GHS) 
GHS07,GHS08
Signal word  Warning
Hazard statements  H317-H319-H341-H351-H361
Precautionary statements  P201-P202-P280-P302+P352-P305+P351+P338-P308+P313
Hazard Codes  Xn
Risk Statements  63-40
Safety Statements  36/37
WGK Germany  3
HS Code  2933595960
Hazardous Substances Data 188062-50-2(Hazardous Substances Data)

RELATED PRODUCTS